Yoshitaka Harada
Overview
Explore the profile of Yoshitaka Harada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harada Y, Ohmuro-Matsuyama Y, Tsuna M, Ueda H
Anal Sci
. 2020 Nov;
37(3):455-459.
PMID: 33229828
Immunochromatography assay is an easy and rapid on-site detection method. However, conventional sandwich immunochromatographies using two antibodies can only detect target molecules above a threshold size. Small molecules below 1000...
2.
Harada Y, Kinoshita F, Yoshida L, Minh L, Suzuki M, Morimoto K, et al.
Pediatr Infect Dis J
. 2013 Jul;
32(5):441-5.
PMID: 23838658
Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection in children less than 5 years of age. The impact of non-RSV respiratory virus coinfection on...
3.
Suzuki M, Yoshimine H, Harada Y, Tsuchiya N, Shimada I, Ariyoshi K, et al.
PLoS One
. 2013 Jan;
8(1):e52103.
PMID: 23326324
Background: Influenza vaccine effectiveness (VE) studies are usually conducted by specialized agencies and require time and resources. The objective of this study was to estimate the influenza VE against medically...
4.
Nagao J, Shioya K, Harada Y, Okuda K, Zendo T, Nakayama J, et al.
Methods Mol Biol
. 2010 Dec;
705:225-36.
PMID: 21125389
Alteration of protein structure and function by introducing unusual amino acids has great potential to develop new biological tool and to produce novel therapeutic agents. Lantibiotics produced by Gram-positive bacteria...
5.
Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, et al.
Vaccine
. 2010 Aug;
28(43):7063-9.
PMID: 20723631
To determine the clinical efficacy and cost-saving effect of pneumococcal polysaccharide vaccine (PPV) against community-acquired pneumonia (CAP), an open-label, randomized clinical trial was conducted involving 786 Japanese subjects older than...
6.
Shioya K, Harada Y, Nagao J, Nakayama J, Sonomoto K
Appl Microbiol Biotechnol
. 2009 Nov;
86(3):891-9.
PMID: 19915831
The lantibiotic nukacin ISK-1 is an antimicrobial peptide containing unusual amino acids such as lanthionine and dehydrobutyrine. The nukacin ISK-1 prepeptide (NukA) undergoes posttranslational modifications, such as the dehydration and...
7.
Okuda K, Yanagihara S, Shioya K, Harada Y, Nagao J, Aso Y, et al.
Appl Environ Microbiol
. 2008 Nov;
74(24):7613-9.
PMID: 18978082
NukH is a lantibiotic-binding immunity protein that shows strong binding activity against type A(II) lantibiotics. In this study, the binding specificity of NukH was analyzed by using derivatives of nukacin...
8.
Takayanagi K, Kimura Y, Kawakami K, Koyama K, Harada Y, Yamaryo T
Kansenshogaku Zasshi
. 2008 Mar;
82(1):43-6.
PMID: 18306679
A 60-year-old woman seen at the National Hospital Organization Nagasaki Medical Center of Neurology with a cough and abnormal chest radiography was found in CT to have interstitial shadows in...
9.
Harada Y, Kawakami K, Koyama K, Yamaryo T, Kimura Y
Kekkaku
. 2007 Nov;
82(9):705-9.
PMID: 17969987
A 65-year-old female was started anti-tuberculous therapy for her pulmonary tuberculosis on admission. Liver dysfunction had occurred on 33rd day after starting treatment. AST was elevated to 301 IU/L, and...
10.
Koyama K, Kawakami K, Harada Y, Yamaryo T, Kimura Y
Kekkaku
. 2007 Aug;
82(7):577-81.
PMID: 17695788
A 31-year-old woman complained of cough and fever for 2 months. She was admitted to a hospital and was diagnosed as pulmonary tuberculosis. She received combination therapy with isoniazid, rifampicin,...